{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "10448927", "DateCompleted": {"Year": "1999", "Month": "09", "Day": "08"}, "DateRevised": {"Year": "2019", "Month": "06", "Day": "24"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "0014-2999", "JournalIssue": {"Volume": "377", "Issue": "1", "PubDate": {"Year": "1999", "Month": "Jul", "Day": "14"}}, "Title": "European journal of pharmacology", "ISOAbbreviation": "Eur J Pharmacol"}, "ArticleTitle": "Inhibition of ozone-induced lung neutrophilia and nuclear factor-kappaB binding activity by vitamin A in rat.", "Pagination": {"StartPage": "63", "EndPage": "68", "MedlinePgn": "63-8"}, "Abstract": {"AbstractText": ["Vitamin A binds to retinoic acid receptors, which in turn may interact with other transcription factors. We determined its effect (2500 and 5000 IU/kg) on nuclear factor-kappaB binding activity in the lung, airway inflammation and bronchial hyperresponsiveness in rats exposed to ozone. Ozone (3 ppm, 3 h) caused neutrophil influx into bronchoalveolar lavage fluid (16.2+/-0.8 x 10(5) cells/ml, p < 0.01) and bronchial hyperresponsiveness (-logPC200ACh = 2.54+/-0.19, p < 0.05, compared to control animals, respectively). Vitamin A inhibited this neutrophilia dose-dependently together with the increased DNA-binding activity of nuclear factor-KB in lung extracts. Vitamin A did not affect bronchial hyperresponsiveness at both doses. Vitamin A inhibits ozone-induced neutrophilic inflammation through a reduction in nuclear factor-kappaB DNA binding activity."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Thoracic Medicine, National Heart and Lung Institute, Imperial College School of Medicine, London, UK."}], "Identifier": [], "LastName": "Hisada", "ForeName": "T", "Initials": "T"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Adcock", "ForeName": "I M", "Initials": "IM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Nasuhara", "ForeName": "Y", "Initials": "Y"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Salmon", "ForeName": "M", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Huang", "ForeName": "T J", "Initials": "TJ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Barnes", "ForeName": "P J", "Initials": "PJ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Chung", "ForeName": "K F", "Initials": "KF"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Eur J Pharmacol", "NlmUniqueID": "1254354", "ISSNLinking": "0014-2999"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "DNA-Binding Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-kappa B"}, {"RegistryNumber": "0", "NameOfSubstance": "Oxidants, Photochemical"}, {"RegistryNumber": "0", "NameOfSubstance": "Vasodilator Agents"}, {"RegistryNumber": "11103-57-4", "NameOfSubstance": "Vitamin A"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "N9YNS0M02X", "NameOfSubstance": "Acetylcholine"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Acetylcholine"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemically induced"], "DescriptorName": "Bronchial Hyperreactivity"}, {"QualifierName": ["cytology"], "DescriptorName": "Bronchoalveolar Lavage Fluid"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Count"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "DNA-Binding Proteins"}, {"QualifierName": ["drug effects", "pathology"], "DescriptorName": "Lung"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "NF-kappa B"}, {"QualifierName": ["drug effects", "pathology"], "DescriptorName": "Neutrophils"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Oxidants, Photochemical"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "Protein Binding"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Inbred BN"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Vasodilator Agents"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Vitamin A"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1999", "Month": "8", "Day": "17"}, {"Year": "1999", "Month": "8", "Day": "17", "Hour": "0", "Minute": "1"}, {"Year": "1999", "Month": "8", "Day": "17", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["10448927", "10.1016/s0014-2999(99)00405-7", "S0014-2999(99)00405-7"]}}], "PubmedBookArticle": []}